Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
Affidea, a European healthcare provider with more than 240 locations, announced it is now implementing Subtle Medical’s SubtlePET solution in its PET-CT center in Italy.
Deep-learning based AI models can identify breast cancer more accurately than radiologists, according to new research published in Nature. What does this mean for the future of cancer detection?
AI in Healthcare spent 2019 tracking the steady evolution of AI and other advanced technologies, paying close attention to how they could change patient care forever. We’ve gathered 10 of the site’s most popular—and compelling—articles from the past 12 months.
Machine learning (ML) can predict a patient’s long-term risk of myocardial infarction (MI) or cardiac death, according to new findings published in Cardiovascular Research.